Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NATTOPHARMA AS
AS
Active
Org 919864559
Etasje 05 Mustads Vei 1, 0283
Oslo
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2017 · 8 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of basic pharmaceutical products
/
NATTOPHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
3M
1M
2018
2M
2019
3M
2020
3M
2021
EBITDA
NOK millions
0M
-4M
-8M
-12M
-16M
-13M
2018
-5M
+62%
2019
-2M
+60%
2020
0M
+100%
2021
Income statement
NOK thousands
Item
2018
2019
2020
2021
Revenue
1 457
1 816
3 208
3 242
Staff expenses
−0
−0
−0
−0
EBITDA
−12 985
−5 287
−2 030
258
Depreciation & amort.
−11 792
−42 266
−1 635
−1 684
EBIT
−24 778
−47 553
−3 664
−1 426
Net financials
−3 119
−2 612
−2 636
−2 540
Profit before tax
−27 897
−50 164
−6 301
−3 966
Tax
−0
−0
−0
−0
Net profit
−27 897
−50 164
−6 301
−3 966
Balance sheet
NOK thousands
Item
2018
2019
2020
2021
Total assets
60 635
14 758
14 047
10 129
Equity
9 494
−40 733
−43 033
−46 999
Long-term debt
38 354
53 633
54 098
56 548
Short-term debt
12 787
1 858
2 983
581
Total debt
51 142
55 491
57 080
57 129
Financial ratios
5-year trend
EBITDA margin
8.0%
This company
15.8%
Market median
-49% vs market
2018
2021
Equity ratio
-464.0%
This company
38.2%
Market median
-1315% vs market
2018
2021
Return on equity
-396600000.0%
This company
18.4%
Market median
-2155434883% vs market
2018
2021
Net profit margin
-122.3%
This company
8.1%
Market median
-1610% vs market
2018
2021
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
2018
2021
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
2018
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2017-10-27 – 2018-12-31
View
PDF
More on NATTOPHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
